Edition:
United Kingdom

CymaBay Therapeutics Inc (CBAY.OQ)

CBAY.OQ on NASDAQ Stock Exchange Capital Market

7.78USD
12 Dec 2017
Change (% chg)

-- (--)
Prev Close
$7.78
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
190,142
52-wk High
$9.40
52-wk Low
$1.46

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.13 December 13 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 4 4 5 5
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.67 1.67 1.71 1.71

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 6 2.25 10.00 0.00 0.00
Quarter Ending Mar-18 5 0.00 0.00 0.00 --
Year Ending Dec-17 6 7.05 14.79 4.79 0.00
Year Ending Dec-18 6 7.67 36.00 0.00 0.00
Earnings (per share)
Quarter Ending Dec-17 6 -0.13 0.03 -0.22 -0.28
Quarter Ending Mar-18 5 -0.21 -0.17 -0.28 --
Year Ending Dec-17 6 -0.82 -0.62 -0.93 -1.11
Year Ending Dec-18 6 -0.90 -0.82 -1.02 -1.07

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 0.00 0.00 0.00 0.00
Quarter Ending Jun-17 0.00 0.00 0.00 0.00
Quarter Ending Mar-17 0.00 4.79 4.79 0.00
Quarter Ending Dec-16 0.00 0.00 0.00 0.00
Quarter Ending Sep-16 0.00 0.00 0.00 0.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 2.25 2.25 2.50 2.00 0.00
Quarter Ending Mar-18 0.00 0.00 0.00 0.07 --
Year Ending Dec-17 7.05 7.05 6.80 6.46 0.00
Year Ending Dec-18 7.67 7.67 11.83 11.60 0.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 0 0
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 0 0 0
Year Ending Dec-18 0 0 0 2
Earnings